Document is current
Any future updates will be listed below
-
Authors
Pyka, Thomas
Weissenrieder, Luis
Zeimpekis, Konstantinos
Sari, Hasan
Caobelli, Federico
Chung, Kevin J.
Nardo, Lorenzo
Rominger, Axel
Mingels, Clemens https://orcid.org/0000-0001-6761-5323
-
Funding
Funding for this research was provided by:
National Institute of Health (R01CA249422)
Vivo Translational Imaging shared resources (NCIP30CA093373)
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 4 January 2026
First Online: 13 January 2026
Declarations
:
: The cantonal ethics committee approved this patient acquisition (KEK-Nr.: 2022–00486). The study was performed in accordance with the declaration of Helsinki.
: Not applicable.
: HS is a full-time employee of Siemens Healthcare AG, Switzerland. AR has received research support and speaker honoraria from Siemens. LN is PI of service agreement with United Imaging Healthcare. LN is site PI of clinical trials supported by Novartis Pharmaceuticals Corporation, Telix Pharmaceuticals, Lantheus Medical Imaging, GE Healthcare and Co-PI of a clinical trial supported by Lilly. LN has a speaker engagement agreement with Lilly. UCC Davis has a share revenue agreement with United Imaging Healthcare. All other authors have no conflicts of interest to report.
